Laverty offer iGeneScreen™ testing

Laverty Pathology are pleased to offer women access to an exciting innovation in pregnancy care. The iGeneScreen™ Non-Invasive Foetal Screening test is now availabe.

iGeneScreen™ – For Patients

  • Make an appointment with your Specialist O&G, Fertility, Ultrasonologist or other doctor familiar with this test.
  • Discuss the iGeneScreen™ test with your Doctor and fill out the request and consent forms.
  • The test can be performed from when you are 12 weeks pregnant.
  • Make sure that you understand the test and all your queries have been answered.
  • Your doctor will inform you of the nearest Laverty Collection Centre designated to collect this specific test.
  • Please note: Tests can be collected from Monday to Thursday until Midday ONLY and all collections must be pre booked.
    Please contact Collections on (02) 9005 7000.
  • The result of your test will be sent directly to your requesting Doctor within approximately 2 weeks.
  • The cost of the test is $1,200.00* and there is no Medicare rebate available. The cost is payable by credit card at the time of your pathology collection. Personal cheques are not accepted.

To download a patient information brochure click here.

iGeneScreen™ – For Doctors

Click here to download an iGeneScreen™ Doctor Information Sheet

Click here to download an iGeneScreen™ Request and Informed Consent Form.

If you would like to be added to the list of Doctors providing this test through Laverty Pathology, please email our marketing department by clicking here  and provide us with your name, practice name, address and phone number and we will include you on the next list update.

iGeneScreen™ is an INEX trademark for the non-invasive prenatal screening test developed by BGI.
Innovations Exchange (INEX) is a leading women’s health molecular diagnostic company focused on the research and development of innovative technology for the advancement of women’s, maternal and fetal health. http://www.inex.sg/

BGI is the world’s largest sequencing and bioinformatics institute for the advancement of genomics research and technology. www.genomics.cn/en

Spirometry Testing at Laverty Pathology

Accurate measurement of ventilatory function is now more accessible.

Measurement of ventilatory function is part of routine assessment of respiratory disease. Spirometry is the lung function test of choice for both diagnosis and serial assessment of obstructive airways disease.

The aim of spirometry in general practice is to assess variability of airflow obstruction, and to measure the degree of airflow obstruction compared with predicted normal values.

Current clinical practice guidelines recommend that all doctors managing asthma and COPD should have access to and use a spirometer for optimal assessment of lung function.

Most adults and children over 7 years of age can perform spirometry.

At Laverty Pathology, we offer accurate spirometry conforming to international standards, performed by experienced technicians, and reported by specialist physicians.

Download Laverty Pathology’s newsletter by clicking this link: Spirometry testing at Laverty Pathology

Spirometry Testing at Laverty Pathology

Accurate measurement of ventilatory function is now more accessible.

Measurement of ventilatory function is part of routine assessment of respiratory disease. Spirometry is the lung function test of choice for both diagnosis and serial assessment of obstructive airways disease.

The aim of spirometry in general practice is to assess variability of airflow obstruction, and to measure the degree of airflow obstruction compared with predicted normal values.

Current clinical practice guidelines recommend that all doctors managing asthma and COPD should have access to and use a spirometer for optimal assessment of lung function.

Most adults and children over 7 years of age can perform spirometry.

At Laverty Pathology, we offer accurate spirometry conforming to international standards, performed by experienced technicians, and reported by specialist physicians.

Download Laverty Pathology’s newsletter here: 

Budget boost for health

The NSW Budget has provided $1.2 billion for major works at hospitals across the state. 

Hospitals across NSW have been received a billion dollar boost in the State Budget, which was handed down today.

Capital projects worth in excess of $1.2 billion will unfold across the state this year, Health Minister Jillian Skinner said. This represents an increase of 10 per cent on last year’s capital works spend.

“The capital funding provisions for health in the NSW Budget is about more than bricks and mortar – it is about building the hospitals and health care facilities our patients and staff expect and deserve,” Skinner said.

Key capital works projects for 2013-14 in the Sydney metropolitan area include: $71.1 million toward the $270 million Blacktown Mount Druitt Hospital expansion Stage 1; $49.8 million to the Campbelltown Hospital redevelopment; $40.6 million for the $120 million Hornsby Ku-ring-gai Hospital Stage 1 redevelopment; and $29.1 million toward the development of the Northern Beaches Health Service.

Key capital works in rural and regional areas include: $32.8 million to commence construction of the new $170.1 million South East Regional Hospital in Bega; $9 million to commence the $80 million redevelopment of Kempsey Hospital; and $8.9 million to start the $80.3 million Lismore Hospital redevelopment.

Skinner said an additional $884 million will be invested in the NSW health system in 2013-14, an increase of 5.2 per cent compared to the previous year. The recurrent budget for NSW Health is now a record $17.9 billion.

The Budget allocated $220 million for an extra 69,000 emergency department attendances, an extra 34,000 patients admitted to hospital including surgery for an extra 3000 patients, extra outpatient clinic appointments and new sub-acute services.

Other Budget measures include:

• $51 million for continued and new investment to bring to market new medical research innovations and life saving devices.

• $30 million for integrated care – building new partnerships with the not-for-profit and private sector to deliver better care in the community.

• $15 million to implement the Reform Plan for the Ambulance Service of NSW, including recommendations relating to aeromedical retrieval.

• $9.2 million for 80 more clinical nurse/midwife specialists and educators, including $3 million for 30 new palliative care nurses across NSW.

 

What do you think of the Budget’s health measures? COMMENT BELOW.

Nationa health performance authority reveals Australia’s worst hospitals for superbug Golden Staph infections

A HIT LIST of the nation’s hospital hot spots reveal more than 1700 patients caught killer superbug infections in public hospitals last year.

Golden Staph is a bloodstream infection that proves fatal in between 20-35 per cent of cases and it is used as a key measure of hospital quality and safety. National Health Performance Authority chief Dr Diane Watson says the new figures allow poorly performing hospitals to measure themselves against the hospitals with the lowest infection rates and lift their game.

Patients can also use the data if they are wondering which might be the best hospital to use for surgery but she warns that patients should be cautious about data for small hospitals where a single case could have a dramatic and unrepresentative impact on the hospitals performance. Health ministers have signed up to a target that aims to keep rates of infection below 2 cases per 10,000 days of treatment. The Prince Charles Hospital in Brisbane had the nation’s lowest rate of infection among major hospitals with just nine cases and a rate of 0.47 cases per 10,000 days of treatment. South Australia’s Royal Adelaide Hospital had the worst rate of infection.

NEW SOUTH WALES

Four of the five major hospitals with the worst infection rates in the country are in NSW. Westmead Hospital in Sydney had the second worst rate of golden staph infection in the country with 62 cases in 2011-12 data from the National Health Performance Authority (NHPA) shows. But St George Hospital (45 cases), John Hunter Hospital (55 cases) and Prince of Wales (39 cases) also had rates of infection that exceeded acceptable levels of two cases per 10,000 days of treatment. The states best performing major hospital in NSW was St Vincents Public which had twelve cases of golden staph and an infection rate of just 0.9 per 10,000 days of treatment.

VICTORIA

While the highest number of cases of golden staph infection occurred at the Monash Medical Centre – where 40 patients caught the bug – the rate of infection was lower at 1.71 cases  per 10,000 treatment days compared to 2.3 at the Peter MacCallum Cancer Institute. The Alfred hospital reported 38 cases of golden staph infection (a rate of 1.58 per 10,000 treatment days) and the Austin Hospital 34 (a rate of 1.48 per 10,000 treatment days). Three hospitals in Victoria – Peter MacCallum, Goulburn Valley Health (2.7 cases per 10,000 treatment days) and the Bairnsdale Regional Health Service (2.01 cases per treatment days) – all had infection rates slightly above the target 2 cases in 10,000 days of treatment rate. Peter MacCallum treats vulnerable cancer patients who are at high risk of infection but it improved its performance over 2010-11 when it had 16 cases of golden staph.

QUEENSLAND

Queensland can boast the lowest infection rate in the country. The Prince Charles Hospital in Brisbane had the nation’s lowest rate of infection among major hospitals with just nine cases and a rate of 0.47 cases per 10,000 days of treatment data from the National Hospital Performance Authority (NHPA) shows. The worst performing hospital in the state was Innisfail Hospital but it treats just over 12,000 patients a year and NHPA chief Dr Diane Watson says reports for hospitals of this size are not reliable because a single extra case can have a huge impact on infection rates. Princess Alexandria Hospital was the worst major hospital with 53 infections in 2011-12 and an infection rate of 1.72 cases per 10,000 days of treatment.

SOUTH AUSTRALIA

The Royal Adelaide Hospital had the highest infection rate in the country among Australia’s major hospitals. Sixty two patients caught a deadly staph infection while being treated at Royal Adelaide Hospital in 2011-12, a rate of 2.15 per 10,000 days of treatment, the highest of any major hospital in the country. The Flinders Medical Centre was the best performing major hospital in the state with just 19 cases and a rate of 0.84 per 10,000 days of treatment. Over the past nine months, the RAH has seen significant improvement with the SAB rate for March 2013 sitting at 1.41 per 10,000 patient bed days,” a SA Health spokesperson said. The golden staph infection rate for South Australia, as at YTD March 2013, is 0.89, a significant improvement from 1.11 per 10,000 days in 2012, and well below the national benchmark.

TASMANIA

Just 10 patients caught golden staph while visiting the Royal Hobart Hospital and another 10 came down with the infection while using the Launceston General Hospital data from the National Hospital Performance Authority shows. The worst performing hospital in the state was Mersey Community Hospital which had three cases among its 22,944 treatment days but the NHPA say data in hospitals this small is unreliable because a single case an have a huge impact on the rate. The rate of infection at the Royal Hobart Hospital was 0.66 cases per 10,000 days of treatment which compares favourably with the hospital with the hospital with the nation’s lowest infection rate – The Prince Charles Hospital in Brisbane (0.47 cases per 10,000).Launceston General Hospital had an infection rate of 0.92 cases per days of treatment.

Deadly disease

“If you get one of these infections they are pretty serious, you have high fever, sweat, chills, it goes to the bones and heart valves,” Australian National University Professor of Infectious Diseases Peter Collignon says. “Overall about 20 per cent of patients die within 30 days,” he said. Patients whose infections were resistant to most antibiotics had an even higher death rate of 35 per cent , he said. Golden Staph is carried by lots of people on their skin and in their nasal passages but it is when it enters the bloodstream through a surgical wound or an intravenous drip line that it becomes dangerous. Poor hand washing rates by doctors and nurses and poor management of intravenous lines were responsible for higher infection rates, Professor Collignon said. Some patients such as those recovering from burns, bone marrow transplants immune system disorders, transplants and renal failure are at higher risk of golden staph. That is why NHPA chief executive Dr Diane Watson says her report groups hospitals into 8 different peer groups reflecting hospital size and the proportion of vulnerable patients in the hospital to make the comparison fair.

Coalition divided over plan for new regional medical school

A FIGHT over a plan to create a new regional medical school could become a political issue after the Nationals signalled strong support for the proposal from Charles Sturt and La Trobe universities.

The established medical schools believe they have headed off the proposal, with Tony Abbott reportedly assuring the medical deans that, like Labor’s Health Minister Tanya Plibersek, he has no plans to back the idea.

Calls for federal ban on synthetic drugs

Pressure is mounting on the federal government to introduce a permanent ban on synthetic drugs in Australia after the death of a Sydney teenager.

A temporary ban has been declared in NSW, after 17-year-old Sydney schoolboy Henry Kwan jumped to his death. He had taken a synthetic hallucinogen that mimics LSD.

Shops selling these substances will be targeted in a statewide crackdown this week, and could face major fines if they breach the ban.

But NSW Fair Trading Minister Anthony Roberts says federal government support will be “crucial” in ensuring the ban on synthetic drugs becomes permanent once it expires in 90 days’ time.

Independent Senator Nick Xenophon said the federal government had the constitutional power to outlaw these drugs, and couldn’t pass off responsibility to the states.

“The fact that the NSW Minister for Fair Trading says the ban can only be temporary without the federal government being involved cries out for federal government action,” he said in a statement.

“For the Health Minister (Tanya Plibersek) to say this is for the states to sort out ignores the constitutional powers to outlaw these drugs.”

Senator Xenophon will next week move a resolution in the upper house calling on the government to act, promising to draft legislation if they failed to do so.

Opposition health spokesman Peter Dutton said these substances posed a “serious public health issue”, and urged Ms Plibersek to immediately canvass all options available for permanently banning them.

“Getting these incredibly dangerous products off the streets should have been an absolute priority for the Health Minister,” he said.

Smartphone app to track NSW baby health

NSW parents will be able to use a smartphone app to access their child’s health records for the first time.

The eBlue Book and smartphone app is an electronic version of the hard copy blue book which NSW Health has been distributing to parents since 1988 to record their babies’ growth into early childhood.

It’s also used to log and monitor information such as height and weight milestones and immunisation history.

The online book and app has now been made available to parents, their GPs and other eligible health workers in the Western Sydney and Blue Mountains Local Health Districts and Medicare Locals.

Health Minister Jillian Skinner says the eBlue Book allows parents access to their child’s health data, “wherever they want it, whenever they want it”.

“It allows parents and carers as well as health-care providers to enter information,” she said.

“This creates a truly shared health record, a very modern tool for parents and carers.”

Parents outside the eBlue Book implementation sites are being urged to continue to use the hard copy of the blue book, with plans to roll out the online version to more sites in the future.

NSW nurses warned against taking action

A western Sydney health boss has warned nurses at Nepean Hospital of “consequences” if they turn away pregnant women because of maternity staff shortages.

Fairfax Media reports that Nepean Blue Mountains Local Health District chief executive, Kay Hyman, issued the warning about the proposed action at Penrith’s Nepean Hospital.

Nurses reportedly plan to turn away pregnant women from the hospital from Monday due to concerns about staff shortages.

Nurses have assured the community that no emergency or “high risk” patients will be rejected from the hospital.

Screen shot 2013-06-05 at 1.56.09 AM